$3m for Vectura as asthma target advances – Cabume – Cambridge technology news

$3m for Vectura as asthma target advances
Cabume – Cambridge technology news
Vectura has achieved a major milestone in its asthma drug target, triggering a $3m (£1.9m) payment from its unnamed US-based pharmaceutical partner and sending its share price up 5.9 per cent to 76.25p a share. That means Vectura is still on for a
Vectura updates on developmental products and milestonesThe Pharma Letter

all 2 news articles »

View full post on asthma – Google News

Cambridge Consultants demos asthma training device – mobihealthnews


Co.Design

Cambridge Consultants demos asthma training device
mobihealthnews
Medical device design and development consultancy Cambridge Consultants showed off its latest creation this week, an asthma inhaler training device called the T-Haler. According to the company the concept device “more than doubles patient compliance.
Wireless asthma inhaler teaches proper useCNET
Smart Inhaler Makes Treating Asthma Into a Video GameCo.Design
T-Haler digital inhaler turns battling asthma into an instructional gameThe Verge
Mass High Tech
all 6 news articles »

View full post on asthma – Google News

T-Haler: Cambridge Consultants’ New Asthma Training Device More Than Doubles … – Dexigner


Dexigner

T-Haler: Cambridge Consultants' New Asthma Training Device More Than Doubles
Dexigner
Cambridge Consultants unveiled T-Haler, an asthma inhaler training device that more than doubles patient compliance. With, on average, more than three Americans going to the emergency room every minute due to asthma attacks, the T-Haler could be a
Inhaler trainer is a breezeCambridge First

all 3 news articles »

View full post on asthma – Google News